| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.SEMARTHRIT.2006.04.008 |
| P698 | PubMed publication ID | 16884971 |
| P2093 | author name string | Chi Chiu Mok | |
| P433 | issue | 2 | |
| P304 | page(s) | 71-81 | |
| P577 | publication date | 2006-07-12 | |
| P1433 | published in | Seminars in Arthritis and Rheumatism | Q15761553 |
| P1476 | title | Therapeutic options for resistant lupus nephritis | |
| P478 | volume | 36 |
| Q37736277 | Biomarkers for lupus nephritis: a critical appraisal |
| Q43101009 | Combination therapy of mycophenolate mofetil and tacrolimus in lupus nephritis |
| Q34362680 | Efficacy and Safety of Treatment with Rituximab for Difficult Steroid-Resistant and -Dependent Nephrotic Syndrome |
| Q46484861 | Efficacy of enteric-coated mycophenolate sodium in patients with resistant-type lupus nephritis: a prospective study. |
| Q37391863 | European consensus statement on the terminology used in the management of lupus glomerulonephritis |
| Q35677419 | Influence of renal complications on the efficacy and adverse events of tacrolimus combination therapy in patients with systemic lupus erythematosus (SLE) during a maintenance phase: a single-centre, prospective study |
| Q89013970 | Intracapillary immune complexes recruit and activate slan-expressing CD16+ monocytes in human lupus nephritis |
| Q43031095 | Long-term outcomes--mycophenolate mofetil treatment for lupus nephritis with addition of tacrolimus for resistant cases. |
| Q38608138 | Lupus nephritis: an update |
| Q33998360 | Lupus nephritis: lessons from murine models |
| Q28071798 | Potential serum and urine biomarkers in patients with lupus nephritis and the unsolved problems |
| Q33560549 | Predictors of relapse and end stage kidney disease in proliferative lupus nephritis: focus on children, adolescents, and young adults. |
| Q40049550 | Response to combination of mycophenolate mofetil, cyclosporin A and corticosteroid treatment in lupus nephritis patients with persistent proteinuria. |
| Q46702259 | Serum and Urinary Interferon-Gamma-Inducible Protein 10 in Lupus Nephritis. |
| Q36664312 | Serum and Urinary Interleukin-6 in Assessment of Renal Activity in Egyptian Patients with Systemic Lupus Erythematosus |
| Q58204824 | Single center prospective study of tacrolimus efficacy and safety in the treatment of various manifestations in systemic lupus erythematosus |
| Q43004356 | Tacrolimus is an alternative therapeutic option for the treatment of refractory lupus nephritis |
| Q37170754 | The role of B lymphocyte stimulator (BLyS) in systemic lupus erythematosus |
| Q42728756 | Treatment of lupus nephritis |
| Q37822658 | Treatment of proliferative lupus nephritis: a slowly changing landscape |
| Q43805398 | Triple immunosuppressive therapy in steroid-resistant nephrotic syndrome children with tacrolimus resistance or tacrolimus sensitivity but frequently relapsing |
| Q37690745 | Update on emerging drug therapies for systemic lupus erythematosus |
Search more.